Contingency Management of Alcohol Abuse in the Severely Mentally ILL (NCT01567943) | Clinical Trial Compass
CompletedNot Applicable
Contingency Management of Alcohol Abuse in the Severely Mentally ILL
United States123 participantsStarted 2012-03
Plain-language summary
The investigators will evaluate the efficacy of a comprehensive 12-week contingency management intervention for treating alcohol dependence for persons with severe mental illness who are seen within the context of a community mental health center setting. The primary contingency will be submission of alcohol-free urines. Additional reinforcers will be provided for intensive outpatient addiction treatment attendance. Reinforcers will be vouchers or actual items useful for day-to-day living. Participants will be 120 adults diagnosed with alcohol dependance and severe mental illness.
Who can participate
Age range18 Years β 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Currently receiving psychiatric \[AND intensive outpatient addiction treatment\] at Community Psychiatric Clinic (CPC).
β. Aged 18 to 65 years.
β. Ability to understand written and spoken English language.
β. DSM-IV diagnosis of alcohol dependence as assessed by the MINI psychiatric interview.
β. Diagnosis of current serious mental illness: schizophrenia, schizoaffective disorders, bipolar disorder I or II, or recurring major depressive disorders as assessed by the MINI psychiatric interview.
β. Alcohol use in the month prior to study entry: self-reported alcohol use of 5 days or more during the 30 days prior to study entry (5 drinking days/month is selected based on previous research reporting alcohol use in 18% of days assessed in a sample of psychiatric outpatients with co-occurring SUDs \& SMI).120
β. A CPC treating clinician must affirm the potential participant is safe to participate in the study.
Exclusion criteria
β. A significant risk of dangerous alcohol withdrawal: a history of alcohol detoxification or seizure in the last 12 months AND participant or clinician concern that abstinence will induce dangerous alcohol withdrawal.
What they're measuring
1
Alcohol Use as Assessed by Ethyl Glucuronide Detection in Urine
Timeframe: Over 16 weeks of treatment (repeated measure)
β. DSM-IV diagnosis of current (last year) drug dependence as assessed by the MINI interview.
β. Any medical/psychiatric condition, or severity of that condition, that in the opinion of the PI, would compromise safe study participation.
β. Chart defined organic brain disorder or dementia.
β. Inability to provide informed consent as measured by the University of California San Diego Brief Assessment of Capacity to Consent (UBACC), a tool designed to screen for ability to provide informed consent for research. If indicated by the UBACC screening process, the more comprehensive MacCAT-CR will be used.